Sun Pharma, Zydus Lifesciences, and Dr. Reddy's have launched generic semaglutide injections in India. This move offers affordable diabetes and obesity drugs.
Laurus is witnessing a strong scale-up in CDMO business from global innovator pharma, including rare formulation-level contracts for patented products, adds Motilal Oswal.
